Related Experiment Video
Updated: Apr 7, 2026

09:58
DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
Published on: June 6, 2025
1.3K
Time-Frequency Analysis of Peptide Microarray Data: Application to Brain Cancer Immunosignatures.
Brian O'Donnell1, Alexander Maurer1, Antonia Papandreou-Suppappola1
1School of Electrical, Computer and Energy Engineering, Arizona State University, Tempe, AZ, USA.
Cancer Informatics
|July 10, 2015
Summary
Early cancer detection is crucial. This study introduces a novel immunosignature assay using peptide sequences to identify cancer biomarkers, potentially enabling earlier tumor diagnosis through an inexpensive immunoassay.
Area of Science:
- Biomarker Discovery
- Immunology
- Bioinformatics
Background:
- Delayed cancer diagnosis poses significant risks to patients.
- Immune system-based assays, like immunosignatures, offer potential for early cancer detection.
- Current immunosignature methods have not fully utilized peptide sequence information.
Purpose of the Study:
- To develop a novel algorithm for extracting meaningful information from peptide sequences within immunosignatures.
- To identify cancer-specific immune responses using antibody-peptide interactions.
- To demonstrate the algorithm's efficacy in detecting Glioblastoma multiforme (GBM).
Main Methods:
- Synthesized 330,000 random-sequence peptides on a microarray.
- Employed time-variant analysis of recurrent subsequences to analyze peptide sequences and binding intensities.
- Validated the algorithm using monoclonal antibodies with known epitopes and patient-derived immunosignatures.
Main Results:
- Developed an algorithm to analyze antibody-peptide binding data and peptide sequences.
- Successfully identified eight different frameshift targets associated with GBM.
- Demonstrated the potential for detecting cancer-specific immune signatures.
Conclusions:
- The developed method effectively extracts valuable information from peptide sequences in immunosignatures.
- This approach may lead to sensitive and inexpensive diagnostic tests for early tumor detection.
- Further research could refine this technique for broader cancer diagnostics.

